Our purpose is to improve lives of those with neurological conditions and where there is neurological co-morbidity in immune-inflammatory disease.

Our aim is to transform neurological care by using advanced biomarker-derived stratification of patient subgroups to deliver targeted treatment through cell therapy that fundamentally improves quality of life.